|
|
|
|
pmid:
|
|
|
|
|
pmid:3360596
|
|
|
|
|
pmid:9870780
|
Pastores SM et al. |
Posttraumatic multiple-organ dysfunction syndrome: role of mediators in systemic inflammation and subsequent organ failure. |
1996 |
Acad Emerg Med |
pmid:8727633
|
Goldring WP and Pattenden G |
The phomactins. A novel group of terpenoid platelet activating factor antagonists related biogenetically to the taxanes. |
2006 |
Acc. Chem. Res. |
pmid:16700534
|
Yamada T et al. |
Effects of inhaled nitric oxide on platelet-activating factor-induced pulmonary hypertension in dogs. |
1998 |
Acta Anaesthesiol Scand |
pmid:9542566
|
Nathan N et al. |
Variations in blood platelet-activating-factor levels after protamine reversal of heparin in humans. |
1992 |
Acta Anaesthesiol Scand |
pmid:1574976
|
Sipka S et al. |
Atropine is an inhibitor of the chemiluminescence induced by platelet-activating factor in human neutrophils. |
1987 |
Acta Biochim. Biophys. Hung. |
pmid:3132002
|
Ren J et al. |
Protective effect of dexmedetomidine against myocardial ischemia-reperfusion injury in rabbits. |
2018 |
Acta Cir Bras |
pmid:29412230
|
Peterson JR et al. |
Platelet activating factor antagonist design. 3. X-ray crystal structure and intermolecular crystal lattice interactions of methyl trans-4-acetoxymethyl-4,5-dihydro-2,5-bis(3,4-methylenedioxyphenyl)- 3-furancarboxylate. |
1989 |
Acta Crystallogr C |
pmid:2604943
|
Peterson JR et al. |
Platelet activating factor antagonist design: structure of methyl trans-5-(3,4-dimethoxyphenyl)-2,3,4,5-tetrahydro-2-oxo-4- furancarboxylate. |
1989 |
Acta Crystallogr C |
pmid:2610971
|
Peterson JR et al. |
Platelet activating factor antagonist design. 2. X-ray structure of dimethyl 2,3,4,5-tetrahydro-5 beta-(3,4-methylenedioxyphenyl)-2-oxo-3 beta-(3,4,5-trimethoxybenzoyl)-3 alpha,4 alpha-furandicarboxylate. |
1989 |
Acta Crystallogr C |
pmid:2610989
|
Stensland JB et al. |
Platelet activating factor antagonists. Structure of N,N'-bis(3,4,5-trimethoxybenzoyl)-2-piperazinylmethyl 2,2-dimethylpropanoate. |
1991 |
Acta Crystallogr C |
pmid:1930821
|
Juhlin L and Pihl-Lundin I |
Effects of antihistamines on cutaneous reactions and influx of eosinophils after local injection of PAF, kallikrein, compound 48/80 and histamine in patients with chronic urticaria and healthy subjects. |
1992 |
Acta Derm. Venereol. |
pmid:1357858
|
Juhlin L and Rihoux JP |
Effect of cetirizine on cutaneous reactions to PAF, kallikrein and serum in patients with chronic urticaria. |
1990 |
Acta Derm. Venereol. |
pmid:1969202
|
Fjellner B and Hägermark O |
Experimental pruritus evoked by platelet activating factor (PAF-acether) in human skin. |
1985 |
Acta Derm. Venereol. |
pmid:2416164
|
Abramovici Y et al. |
Control of the proliferation and differentiation of GEJ under platelet aggregating factor treatment. |
1987 |
Acta Endocrinol Suppl (Copenh) |
pmid:3475908
|
Plachot M |
Markers for establishing the adequacy of embryonal development in assisted conception. |
1993 Sep-Oct |
Acta Eur. Fertil. |
pmid:7985464
|
Aderka D et al. |
Morphological platelet anomalies in thrombotic thrombocytopenic purpura. |
1982 |
Acta Haematol. |
pmid:6801893
|
Bussolino F et al. |
Platelet-activating factor--a powerful lipid autacoid possibly involved in microangiopathy. |
1986 |
Acta Haematol. |
pmid:3019063
|
Akisü M et al. |
The effect of L-carnitine on platelet activating factor concentration in the immature rat model of hypoxic-ischemic brain injury. |
1998 |
Acta Med. Okayama |
pmid:9781268
|
Hashimoto K et al. |
Comparison of the effects of intra-third ventricular administration of interleukin-1 or platelet activating factor on ACTH secretion and the sympathetic-adrenomedullary system in conscious rats. |
1993 |
Acta Med. Okayama |
pmid:8384777
|
Vargaftig BB et al. |
One, two, three or more pathways for platelet aggregation. |
1980 |
Acta Med. Scand. Suppl. |
pmid:6779505
|
Hirasima Y et al. |
Platelet-activating factor (PAF) and the development of chronic subdural haematoma. |
1994 |
Acta Neurochir (Wien) |
pmid:7998491
|
Hirashima Y et al. |
Platelet-activating factor (PAF) and the formation of chronic subdural haematoma. Measurement of plasma PAF levels and anti-PAF immunoglobulin titers. |
1995 |
Acta Neurochir (Wien) |
pmid:8748861
|
Hirashima Y et al. |
Platelet-activating factor and antiphospholipid antibodies in subarachnoid haemorrhage. |
1994 |
Acta Neurochir (Wien) |
pmid:7847132
|
Hallenbeck JM |
Blood-damaged tissue interaction in experimental brain ischemia. |
1994 |
Acta Neurochir Suppl (Wien) |
pmid:7976554
|
Tokutomi T et al. |
Effect of platelet-activating factor antagonist on brain injury in rats. |
1994 |
Acta Neurochir Suppl (Wien) |
pmid:7976632
|
Maeda T et al. |
Hemodynamic depression and microthrombosis in the peripheral areas of cortical contusion in the rat: role of platelet activating factor. |
1997 |
Acta Neurochir. Suppl. |
pmid:9416292
|
Khan SN et al. |
Response to platelet-activating factor of platelets from patients with multiple sclerosis. |
1985 |
Acta Neurol. Scand. |
pmid:3993327
|
Satoh K et al. |
Increased levels of blood platelet-activating factor (PAF) and PAF-like lipids in patients with ischemic stroke. |
1992 |
Acta Neurol. Scand. |
pmid:1574985
|
Doly M et al. |
Protective effect of a specific PAF antagonist on vincristine-induced experimental retinopathy. |
1995 |
Acta Ophthalmol Scand |
pmid:7656145
|
Pettorossi VE and Grassi S |
Different contributions of platelet-activating factor and nitric oxide in long-term potentiation of the rat medial vestibular nuclei. |
2001 |
Acta Otolaryngol Suppl |
pmid:11677732
|
Nakano T et al. |
Roxythromycin reinforces epithelial defence function in rabbit trachea. |
1998 |
Acta Otolaryngol Suppl |
pmid:9879427
|
Minami T et al. |
Regional blood flow volume in the eustachian tube. |
1993 |
Acta Otolaryngol Suppl |
pmid:8452027
|
Lin J et al. |
Effects of platelet-activating factor (PAF) receptor blockage on mucous glycoprotein secretion in cultured chinchilla middle ear epithelium. |
1996 |
Acta Otolaryngol. |
pmid:8820353
|
Terada N et al. |
The effect of anti-VLA-4 monoclonal antibody on eosinophil accumulation and leukotriene production in nasal mucosa. |
1996 |
Acta Otolaryngol. |
pmid:8973726
|
Ganbo T and Hisamatsu K |
Mucosal dysfunction and damage induced by platelet activating factor (PAF). |
1990 Nov-Dec |
Acta Otolaryngol. |
pmid:2284918
|
Minami T et al. |
Effects of various inflammatory mediators on eustachian tube patency. |
1992 |
Acta Otolaryngol. |
pmid:1442015
|
Dolata J et al. |
The influence of leukotrienes and platelet activating factor on mucociliary activity in the rabbit maxillary sinus. |
1990 Jan-Feb |
Acta Otolaryngol. |
pmid:2309553
|
Furukawa M et al. |
Presence of platelet-activating factor in nasal polyps and eosinophils. |
2002 |
Acta Otolaryngol. |
pmid:12542208
|
Lin J et al. |
Dexamethasone inhibits mucous glycoprotein secretion via a phospholipase A2-dependent mechanism in cultured chinchilla middle ear epithelial cells. |
1997 |
Acta Otolaryngol. |
pmid:9199527
|
Bellioni P et al. |
[Histomorphological changes in nasal polyps in patients with glucose metabolism disorders]. |
1988 Nov-Dec |
Acta Otorhinolaryngol Ital |
pmid:3247845
|
Akisü M et al. |
Plasma platelet-activating factor levels in newborn infants with and without perinatal asphyxia: is it an additional marker of perinatal asphyxia? |
1998 |
Acta Paediatr Jpn |
pmid:9821700
|
Hüseyinov A et al. |
Plasma and urinary platelet activating factor concentrations and leukotriene releasing activity of leukocytes in steroid sensitive nephrotic syndrome of childhood. |
1998 |
Acta Paediatr Jpn |
pmid:9583202
|
Nagakura T et al. |
Chemical mediators in hypersensitivity reactions. |
1990 |
Acta Paediatr Jpn |
pmid:1974103
|
Ewer AK |
Role of platelet-activating factor in the pathophysiology of necrotizing enterocolitis. |
2002 |
Acta Paediatr Suppl |
pmid:12200892
|
Hsueh W et al. |
Platelet-activating factor, tumor necrosis factor, hypoxia and necrotizing enterocolitis. |
1994 |
Acta Paediatr Suppl |
pmid:8086673
|
Dahlbäck M et al. |
Bronchial anaphylaxis in actively sensitized Sprague Dawley rats: studies on mediators involved. |
1984 |
Acta Pharmacol Toxicol (Copenh) |
pmid:6431753
|
Saeed SA and Rasheed H |
Calcium-dependent synergistic interaction of platelet activating factor and epinephrine in human platelet aggregation. |
2003 |
Acta Pharmacol. Sin. |
pmid:12511226
|
Penna C et al. |
Post-ischaemic activation of kinases in the pre-conditioning-like cardioprotective effect of the platelet-activating factor. |
2009 |
Acta Physiol (Oxf) |
pmid:19432589
|
Lang F et al. |
Osmotic shock-induced suicidal death of erythrocytes. |
2006 May-Jun |
Acta Physiol (Oxf) |
pmid:16734755
|
Kecskemeti V |
Electrophysiological effects of platelet-activating factor (PAF) in guinea-pig cardiac preparations. |
1990 |
Acta Physiol Hung |
pmid:2371852
|
Balogh I et al. |
Cytochemical effects of biologically active substances on the heart muscle. |
1990 |
Acta Physiol Hung |
pmid:2371866
|
Alving K et al. |
The possible role of prostaglandin D2 in the long-lasting airways vasodilatation induced by allergen in the sensitized pig. |
1991 |
Acta Physiol. Scand. |
pmid:1957709
|
Arner M and Högestätt ED |
Endothelium-dependent relaxation and effects of prostacyclin, endothelin and platelet-activating factor in human hand veins and arteries. |
1991 |
Acta Physiol. Scand. |
pmid:1715111
|
Björk J et al. |
Paf-acether (platelet-activating factor) increases microvascular permeability and affects endothelium-granulocyte interaction in microvascular beds. |
1983 |
Acta Physiol. Scand. |
pmid:6659994
|
Karlström G et al. |
Renal and circulatory effects of medullipin I, as studied in the in-vivo cross-circulated isolated kidney and intact Wistar-Kyoto (WKY) rat. |
1989 |
Acta Physiol. Scand. |
pmid:2603751
|
Iversen VV et al. |
Platelet activating factor (PAF) increases plasma protein extravasation and induces lowering of interstitial fluid pressure (P) in rat skin. |
2005 |
Acta Physiol. Scand. |
pmid:16128692
|
Greiff L et al. |
Effects of topical platelet activating factor on the guinea-pig tracheobronchial mucosa in vivo. |
1997 |
Acta Physiol. Scand. |
pmid:9338520
|
Zia-ul-Haq M et al. |
Platelet aggregation and anti-inflammatory effects of garden pea, Desi chickpea and Kabuli chickpea. |
2012 Jul-Aug |
Acta Pol Pharm |
pmid:22876614
|
Rubio de Krömer MT et al. |
Differences in eosinophil and neutrophil chemotactic responses in sowda and generalized form of onchocerciasis. |
1995 |
Acta Trop. |
pmid:8546035
|
Konstantinov SM et al. |
Efficacy of anticancer alkylphosphocholines in Trypanosoma brucei subspecies. |
1997 |
Acta Trop. |
pmid:9107362
|
Dutra PM et al. |
Stimulation of Leishmania tropica protein kinase CK2 activities by platelet-activating factor (PAF). |
2009 |
Acta Trop. |
pmid:19433049
|
Bazan NG and Allan G |
Platelet-activating factor is both a modulator of synaptic function and a mediator of cerebral injury and inflammation. |
1996 |
Adv Neurol |
pmid:8790822
|
Söling HD et al. |
Regulation of protein kinases in exocrine secretory cells during agonist-induced exocytosis. |
1985 |
Adv. Enzyme Regul. |
pmid:4072796
|
Armant DR |
Intracellular Ca2+ signaling and preimplantation development. |
2015 |
Adv. Exp. Med. Biol. |
pmid:25956298
|
|
Proceedings of an International Symposium on Mechanisms of Platelet Activation and Control. London, United Kingdom, April 13-14, 1992. |
1993 |
Adv. Exp. Med. Biol. |
pmid:7911646
|
Shimizu T and Mutoh H |
Structure and regulation of platelet activating factor receptor gene. |
1997 |
Adv. Exp. Med. Biol. |
pmid:9321953
|
Mori M et al. |
Localization of platelet-activating factor receptor in the rat brain. |
1997 |
Adv. Exp. Med. Biol. |
pmid:9321976
|
Kornecki E et al. |
Interactions of the alkyl-ether-phospholipid, platelet activating factor (PAF) with platelets, neural cells, and the psychotropic drugs triazolobenzodiazepines. |
1987 |
Adv. Exp. Med. Biol. |
pmid:2893525
|
Erickson KL et al. |
Alteration of platelet activating factor-induced macrophage tumoricidal response, IA expression, and signal transduction by N-3 fatty acids. |
1997 |
Adv. Exp. Med. Biol. |
pmid:9321978
|
Muguruma K et al. |
The central role of PAF in necrotizing enterocolitis development. |
1997 |
Adv. Exp. Med. Biol. |
pmid:9321979
|
Aoki Y et al. |
A simple, rapid and specific radioreceptor assay for platelet-activating factor. |
1997 |
Adv. Exp. Med. Biol. |
pmid:9321990
|
Si Y et al. |
The change in plasma PAF activity before and after delivery. |
1997 |
Adv. Exp. Med. Biol. |
pmid:9322006
|
Bourgain RH et al. |
Vivo effects of PAF-acether and arterial thrombosis. |
1986 |
Adv. Exp. Med. Biol. |
pmid:3799334
|
Morooka S and Natsume Y |
Effect of SM-12502 on disseminated intravascular coagulation (DIC) in tumor-bearing rats. |
1996 |
Adv. Exp. Med. Biol. |
pmid:9131147
|
Sanchez Crespo M et al. |
Platelet-activating factor is an effector of rapid reactions and an inductor of late responses in immune-mediated injury. |
1996 |
Adv. Exp. Med. Biol. |
pmid:9131148
|
Ohkuni H et al. |
Purification and partial characterization of a novel human platelet aggregation factor in the extracellular products of Streptococcus mitis, strain Nm-65. |
1997 |
Adv. Exp. Med. Biol. |
pmid:9331745
|
Saito K |
PAF response to inflammatory and non-inflammatory stimuli. |
1996 |
Adv. Exp. Med. Biol. |
pmid:9131150
|
Silver D et al. |
Role of platelet-activating factor in skeletal muscle ischemia-reperfusion injury. |
1996 |
Adv. Exp. Med. Biol. |
pmid:9131151
|
Lopes-Martins RA et al. |
Platelet-activating factor. A possible role in the modulation of the vasomotor tone and blood pressure. |
1996 |
Adv. Exp. Med. Biol. |
pmid:9131152
|
Camussi G et al. |
Platelet-activating factor and angiogenesis. |
1996 |
Adv. Exp. Med. Biol. |
pmid:9131153
|
Oh-Ishi S et al. |
Role of synergistic action of PAF and kinin in bacterial endotoxin-induced hypotension in rats. |
1996 |
Adv. Exp. Med. Biol. |
pmid:9131154
|
Tetta C et al. |
The role of platelet-activating factor in the biocompatibility of hemodialysis membranes. |
1996 |
Adv. Exp. Med. Biol. |
pmid:9131156
|
O'Neill C |
PAF promotes the development of the preimplantation embryo. |
1996 |
Adv. Exp. Med. Biol. |
pmid:9131158
|
Ammit AJ and O'Neill C |
PAF released by preimplantation embryos binds to albumin. |
1996 |
Adv. Exp. Med. Biol. |
pmid:9131159
|
Narahara H et al. |
Role of platelet-activating factor in parturition. |
1996 |
Adv. Exp. Med. Biol. |
pmid:9131160
|
Ahmed A and Dearn S |
The role of platelet-activating factor and its receptor in endometrial receptivity. |
1996 |
Adv. Exp. Med. Biol. |
pmid:9131161
|
Bussolino F et al. |
Role of platelet activating factor in the adhesion process of polymorphonuclear neutrophils to endothelial cells. |
1991 |
Adv. Exp. Med. Biol. |
pmid:1767755
|
Camussi G et al. |
The release of platelet-activating factor during phagocytosis by polymorphonuclear neutrophils and monocytes. |
1982 |
Adv. Exp. Med. Biol. |
pmid:7090917
|
Hallam TJ et al. |
Control and interrelation of aggregation and secretion; the roles of Ca2+, diacylglycerol and thromboxane with particular reference to ADP stimulation. |
1985 |
Adv. Exp. Med. Biol. |
pmid:3010663
|
Gerrard JM et al. |
Platelet protein phosphorylation. |
1985 |
Adv. Exp. Med. Biol. |
pmid:3010667
|
Haslam RJ et al. |
Receptor-effector coupling in platelets: roles of guanine nucleotides. |
1985 |
Adv. Exp. Med. Biol. |
pmid:3010668
|
Droy-Lefaix MT et al. |
Effect of the platelet-activating factor (PAF) antagonist, BN 52021, on free radical-induced intestinal ischemia-reperfusion damage in the rat. |
1990 |
Adv. Exp. Med. Biol. |
pmid:2244522
|
Kosar-Hashemi B et al. |
Glyceryl ether monooxygenase [EC 1.14.16.5]: stoichiometry and inhibition. |
1993 |
Adv. Exp. Med. Biol. |
pmid:8304231
|
Braquet P and Bourgain RH |
Anti-anaphylactic properties of BN 52021: a potent platelet activating factor antagonist. |
1987 |
Adv. Exp. Med. Biol. |
pmid:3314403
|
Winkler JD et al. |
Inhibitors of arachidonate metabolism and effects on PAF production. |
1996 |
Adv. Exp. Med. Biol. |
pmid:9131119
|
Damas J et al. |
Endotoxin shock, kinin system and PAF-acether in the rat. |
1989 |
Adv. Exp. Med. Biol. |
pmid:2610092
|
Vadas P and Pruzanski W |
Phospholipase A2 activation is the pivotal step in the effector pathway of inflammation. |
1990 |
Adv. Exp. Med. Biol. |
pmid:2239447
|